Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells

Hengning Ke1, Katarzyna Chmielarska Masoumi1, Kristofer Ahlqvist1

  • 1Molecular Tumor Pathology, Department of Laboratory Medicine, Lund University, Sweden.

Scientific Reports
|April 2, 2016
PubMed

Insights

Nemo-like kinase (NLK) deficiency causes lung maturation defects, leading to smaller alveoli and respiratory distress. This study reveals NLK

Area of Science:

  • Developmental Biology
  • Molecular Signaling
  • Pulmonary Medicine

Background:

  • Canonical Wnt signaling regulates cell fate and tissue development.
  • Wnt signaling can be inhibited by nemo-like kinase (NLK) through Tcf/Lef phosphorylation.
  • Proper lung development relies on intricate epithelial-endothelial cell crosstalk.

Purpose of the Study:

  • To investigate the role of nemo-like kinase (NLK) in lung development.
  • To elucidate the molecular mechanisms underlying NLK-mediated lung morphogenesis.
  • To understand the link between Wnt signaling inhibition and lung maturation.

Main Methods:

  • Generation and analysis of nemo-like kinase (NLK)-deficient mice.
  • Histological examination of NLK-/- lung tissues to assess alveolar and mesenchymal development.
  • Molecular analysis of gene expression, including vascular endothelial growth factor (VEGF) and its signaling pathway.

Main Results:

  • NLK-deficient mice exhibit cyanosis and severe lung maturation defects, characterized by compressed alveoli and hyperplastic mesenchyme.
  • NLK deficiency leads to epithelial activation of VEGF expression via Lef1 recruitment to the VEGF promoter.
  • Upregulated VEGF signaling promotes increased proliferation of lung epithelial and endothelial cells.

Conclusions:

  • Nemo-like kinase (NLK) is essential for normal lung development and maturation.
  • NLK regulates lung morphogenesis by controlling the epithelial-endothelial cell communication axis through VEGF signaling.
  • Targeting NLK or downstream VEGF pathways may offer therapeutic strategies for lung developmental disorders.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K